US Patent 8450471 TAL effector-mediated DNA modification

US Patent 12105089 Cell atlas of the healthy and ulcerative colitis human colon

US Patent 12091681 Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy

US Patent 12084663 Incorporation of unnatural amino acids into proteins using base editing

US Patent 12006520 Evaluation and improvement of nuclease cleavage specificity

US Patent 12006508 Methods and products for expressing proteins in cells

US Patent 11999947 Adenosine nucleobase editors and uses thereof

US Patent 11994512 Single-cell genomic methods to generate ex vivo cell systems that recapitulate in vivo biology with improved fidelity

US Patent 11981922 Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment

US Patent 11981892 Compositions and methods for improved gene editing

US Patent 11963966 Compositions and methods for treating ovarian tumors

US Patent 11959094 Methods and compositions for genome editing in non-dividing cells

US Patent 11957695 Methods and compositions targeting glucocorticoid signaling for modulating immune responses

US Patent 11957115 Genetically modified mouse expressing human APOE4 and mouse Trem2 p.R47H and methods of use thereof

US Patent 11932884 High efficiency base editors comprising Gam

US Patent 11920181 Nuclease profiling system

US Patent 11920140 Organelle genome modification using polynucleotide guided endonuclease

US Patent 11912985 Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence

US Patent 11904023 Nucleic acid products and methods of administration thereof